AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2012
Mar 19, 2012
30826_dirs_2012-03-19_dcbbea78-e701-44f7-ad0d-f464aa51c809.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2012-03-15
Reporting Person: HERLIHY WALTER C (Director, PRESIDENT, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-15 | Common Stock | M | 50000 | $3.24 | Acquired | 502203 | Direct |
| 2012-03-15 | Common Stock | F | 33265 | $4.87 | Disposed | 468938 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-15 | Stock Option (Right to Buy) | $3.24 | M | 50000 | Disposed | 2012-04-11 | Common Stock (50000) | Direct |
Footnotes
F1: Payment made via forfeiture of 33,265 shares of Common Stock valued at the Closing Price of $4.87 on March 15, 2012.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23